Patent: 5,559,213
✉ Email this page to a colleague
Summary for Patent: 5,559,213
| Title: | Polyethylene-protein conjugates |
| Abstract: | The present invention is a physiologically active, substantially non-immunogenic water soluble polyethylene glycol protein conjugate having the same utility as the protein which forms the conjugate, without having the same properties of producing an immunogenic response possessed by the protein which forms this conjugate. |
| Inventor(s): | John Hakimi, Patricia Kilian, Perry Rosen |
| Assignee: | Hoffmann La Roche Inc |
| Application Number: | US08/457,057 |
| Patent Claims: | see list of patent claims |
| Patent landscape, scope, and claims summary: |
More… ↓ |
Details for Patent 5,559,213
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Schering Corporation A Subsidiary Of Merck & Co., Inc. | PEGINTRON/ REBETOL COMBO PACK | peginterferon alfa-2b and ribavirin | 125196 | June 13, 2008 | 5,559,213 | 2015-06-01 | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
